Evidence of a novel docetaxel sensitizer, garlic‐derived S‐allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer
Explore this paper's citation graph
Summary
A potential role for SAMC is implied in improving docetaxel based chemotherapy for the treatment of hormone refractory prostate cancer through promoting G2/M cell cycle arrest and apoptosis.
- Type
- article
- Published
- 2008-05-01
- Cited by
- 39
- References
- 42
- OpenAlex
- https://openalex.org/W18183597
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:9924503
Keywords
Humanities, Art
References
- Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules
- Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for Docetaxel
- Chemotherapy for hormone-refractory prostate cancer.
- Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
- Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
- Microtubules, microtubule-interfering agents and apoptosis
- Intake of garlic and its bioactive components.
- Clarifying the real bioactive constituents of garlic.
- Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer.
- Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2
- Cytotoxic chemotherapy for advanced hormone‐resistant prostate cancer
- Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma Cells*
- Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.
- Potential for improvement of docetaxel-based chemotherapy: a pharmacological review
- Phase I/II Study of Weekly Docetaxel and Vinblastine in the Treatment of Metastatic Hormone‐Refractory Prostate Carcinoma
- Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl‐2 and Bcl‐xL genes
- PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.
- Pharmacokinetics of the Garlic Compound S-Allylcysteine
- The changing pattern of management for hormone-refractory, metastatic prostate cancer
- Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers
Cited by
- Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: Structure—activity relationships and potent antileukemic and antilymphoma cytotoxicity
- Dietary supplements and natural products in breast cancer trials.
- In vivo Evidence of γ-Tocotrienol as a Chemosensitizer in the Treatment of Hormone-Refractory Prostate Cancer
- Antioxidative Effect of S-allylmercaptocysteine Derived from Aged Garlic on Oxidation of Human Low Density Lipoprotein
- Apoptosis in MCF-7 breast cancer cells induced by S-alkenylmercaptocysteine (CySSR) species derived from Allium tissues in combination with sodium selenite.
- Anti-Cancer Effect of the Combination of Thiacremonone and Docetaxel by Inactivation of NF-κB in Human Cancer Cells
- Drug Interactions with Herbal Medicines
- S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
- Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
- Phenethyl Isothiocyanate Sensitizes Androgen-independent Human Prostate Cancer Cells to Docetaxel-Induced Apoptosis In Vitro and In Vivo
- Garlic in health and disease
- Anti-Inflammatory Agents for Cancer Therapy
- Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population
- [Histological modifications observed in prostate after preserving treatments for prostate cancer and their impact on Gleason score interpretation].
- Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer.
- Identification and characterization of novel antileukemia and anti-lymphoma compounds
- Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
- Downregulation of importin-9 protects MCF-7 cells against apoptosis induced by the combination of garlic-derived alliin and paclitaxel.
- TESIS QUE PARA OBTENER EL GRADO DE MAESTRO EN CIENCIAS DE LA SALUD PRESENTA
- Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation
Related papers
No related papers recorded.